US Stock MarketDetailed Quotes

Anika Therapeutics (ANIK)

Watchlist

14.770
-0.370-2.44%

Close May 8 16:00 ET

14.770
0.0000.00%

Post 16:10 ET

196.52MMarket Cap-18.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anika Therapeutics (ANIK) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

13.16%29.61M

-5.91%112.82M

0.04%30.62M

-5.89%27.82M

-8.15%28.22M

-9.83%26.17M

-0.73%119.91M

1,155.61%30.6M

-28.71%29.56M

-30.65%30.72M

Operating revenue

13.16%29.61M

-5.91%112.82M

0.04%30.62M

-5.89%27.82M

-8.15%28.22M

-9.83%26.17M

-0.73%119.91M

1,155.61%30.6M

-28.71%29.56M

-30.65%30.72M

Cost of revenue

-7.59%10.62M

11.62%49.01M

-15.14%11.44M

20.51%12.23M

35.38%13.86M

14.33%11.49M

14.76%43.91M

255.40%13.48M

-38.56%10.15M

-33.24%10.24M

Gross profit

29.40%19M

-16.04%63.81M

11.99%19.18M

-19.70%15.58M

-29.90%14.36M

-22.63%14.68M

-7.92%76M

196.66%17.13M

-22.19%19.41M

-29.28%20.49M

Operating expense

29.11%24.49M

-7.70%74.86M

3.94%18.53M

-3.45%18.82M

-16.84%18.54M

-11.71%18.97M

-0.72%81.1M

194.20%17.83M

-40.25%19.49M

-31.60%22.3M

Selling and administrative expenses

37.70%17.77M

-11.64%49.09M

6.68%12.08M

-12.35%11.87M

-21.69%12.23M

-14.37%12.91M

-7.29%55.56M

172.65%11.32M

-45.45%13.54M

-34.07%15.62M

Research and development costs

10.79%6.71M

0.88%25.77M

-0.85%6.45M

16.82%6.95M

-5.52%6.31M

-5.46%6.06M

17.37%25.54M

294.70%6.51M

-23.68%5.95M

-25.04%6.68M

Operating profit

-28.10%-5.49M

-116.64%-11.05M

191.63%646K

-3,891.36%-3.23M

-130.94%-4.18M

-71.02%-4.28M

-704.38%-5.1M

-102.85%-705K

98.94%-81K

50.15%-1.81M

Net non-operating interest income expense

60.72%667K

-25.37%1.74M

-84.14%118K

145.57%997K

-64.03%214K

-29.90%415K

1.08%2.34M

28.94%744K

-36.06%406K

6.06%595K

Non-operating interest income

----

-64.03%214K

----

-36.06%406K

--595K

Total other finance cost

-60.72%-667K

25.37%-1.74M

84.14%-118K

-145.57%-997K

----

29.90%-415K

-1.08%-2.34M

-28.94%-744K

36.06%-406K

-6.06%-595K

Other net income (expense)

-3.1M

Special income (charges)

----

---3.1M

----

-Less:Impairment of capital assets

----

--3.1M

----

Income before tax

-24.61%-4.82M

-236.72%-9.31M

1,858.97%764K

-788.00%-2.24M

-226.42%-3.97M

-102.25%-3.87M

-187.58%-2.76M

-99.85%39K

104.62%325K

60.42%-1.22M

Income tax

164.04%235K

-88.92%672K

-141.07%-1.04M

-56.73%939K

-48.64%681K

106.98%89K

-8.05%6.06M

-72.10%2.53M

568.68%2.17M

503.04%1.33M

Net income

-3.76%-5.06M

80.70%-10.88M

101.34%292K

92.22%-2.33M

-4,411.36%-3.97M

-7.95%-4.87M

31.79%-56.39M

65.29%-21.87M

-354.96%-29.92M

96.79%-88K

Net income continuous Operations

-27.74%-5.06M

-13.04%-9.98M

172.45%1.8M

-72.09%-3.18M

-82.88%-4.65M

-102.35%-3.96M

-156.70%-8.83M

-115.32%-2.49M

71.94%-1.85M

7.30%-2.54M

Net income discontinuous operations

--0

98.11%-901K

92.21%-1.51M

103.01%846K

-72.40%677K

64.23%-915K

39.97%-47.56M

---19.38M

---28.07M

--2.45M

Minority interest income

Net income attributable to the parent company

-3.76%-5.06M

80.70%-10.88M

101.34%292K

92.22%-2.33M

-4,411.36%-3.97M

-7.95%-4.87M

31.79%-56.39M

65.29%-21.87M

-354.96%-29.92M

96.79%-88K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-3.76%-5.06M

80.70%-10.88M

101.34%292K

92.22%-2.33M

-4,411.36%-3.97M

-7.95%-4.87M

31.79%-56.39M

65.29%-21.87M

-354.96%-29.92M

96.79%-88K

Basic earnings per share

-8.82%-0.37

80.16%-0.76

101.33%0.02

92.12%-0.16

-2,700.00%-0.28

-9.68%-0.34

32.09%-3.83

65.12%-1.5

-351.11%-2.03

94.74%-0.01

Diluted earnings per share

-8.82%-0.37

80.16%-0.76

101.33%0.02

92.12%-0.16

-2,700.00%-0.28

-9.68%-0.34

32.09%-3.83

65.12%-1.5

-351.11%-2.03

94.74%-0.01

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	13.16%29.61M	-5.91%112.82M	0.04%30.62M	-5.89%27.82M	-8.15%28.22M	-9.83%26.17M	-0.73%119.91M	1,155.61%30.6M	-28.71%29.56M	-30.65%30.72M
Operating revenue	13.16%29.61M	-5.91%112.82M	0.04%30.62M	-5.89%27.82M	-8.15%28.22M	-9.83%26.17M	-0.73%119.91M	1,155.61%30.6M	-28.71%29.56M	-30.65%30.72M
Cost of revenue	-7.59%10.62M	11.62%49.01M	-15.14%11.44M	20.51%12.23M	35.38%13.86M	14.33%11.49M	14.76%43.91M	255.40%13.48M	-38.56%10.15M	-33.24%10.24M
Gross profit	29.40%19M	-16.04%63.81M	11.99%19.18M	-19.70%15.58M	-29.90%14.36M	-22.63%14.68M	-7.92%76M	196.66%17.13M	-22.19%19.41M	-29.28%20.49M
Operating expense	29.11%24.49M	-7.70%74.86M	3.94%18.53M	-3.45%18.82M	-16.84%18.54M	-11.71%18.97M	-0.72%81.1M	194.20%17.83M	-40.25%19.49M	-31.60%22.3M
Selling and administrative expenses	37.70%17.77M	-11.64%49.09M	6.68%12.08M	-12.35%11.87M	-21.69%12.23M	-14.37%12.91M	-7.29%55.56M	172.65%11.32M	-45.45%13.54M	-34.07%15.62M
Research and development costs	10.79%6.71M	0.88%25.77M	-0.85%6.45M	16.82%6.95M	-5.52%6.31M	-5.46%6.06M	17.37%25.54M	294.70%6.51M	-23.68%5.95M	-25.04%6.68M
Operating profit	-28.10%-5.49M	-116.64%-11.05M	191.63%646K	-3,891.36%-3.23M	-130.94%-4.18M	-71.02%-4.28M	-704.38%-5.1M	-102.85%-705K	98.94%-81K	50.15%-1.81M
Net non-operating interest income expense	60.72%667K	-25.37%1.74M	-84.14%118K	145.57%997K	-64.03%214K	-29.90%415K	1.08%2.34M	28.94%744K	-36.06%406K	6.06%595K
Non-operating interest income	----	----	----	----	-64.03%214K	----	----	----	-36.06%406K	--595K
Total other finance cost	-60.72%-667K	25.37%-1.74M	84.14%-118K	-145.57%-997K	----	29.90%-415K	-1.08%-2.34M	-28.94%-744K	36.06%-406K	-6.06%-595K
Other net income (expense)									-3.1M
Special income (charges)	----	----	----	----	----	----	----	----	---3.1M	----
-Less:Impairment of capital assets	----	----	----	----	----	----	----	----	--3.1M	----
Income before tax	-24.61%-4.82M	-236.72%-9.31M	1,858.97%764K	-788.00%-2.24M	-226.42%-3.97M	-102.25%-3.87M	-187.58%-2.76M	-99.85%39K	104.62%325K	60.42%-1.22M
Income tax	164.04%235K	-88.92%672K	-141.07%-1.04M	-56.73%939K	-48.64%681K	106.98%89K	-8.05%6.06M	-72.10%2.53M	568.68%2.17M	503.04%1.33M
Net income	-3.76%-5.06M	80.70%-10.88M	101.34%292K	92.22%-2.33M	-4,411.36%-3.97M	-7.95%-4.87M	31.79%-56.39M	65.29%-21.87M	-354.96%-29.92M	96.79%-88K
Net income continuous Operations	-27.74%-5.06M	-13.04%-9.98M	172.45%1.8M	-72.09%-3.18M	-82.88%-4.65M	-102.35%-3.96M	-156.70%-8.83M	-115.32%-2.49M	71.94%-1.85M	7.30%-2.54M
Net income discontinuous operations	--0	98.11%-901K	92.21%-1.51M	103.01%846K	-72.40%677K	64.23%-915K	39.97%-47.56M	---19.38M	---28.07M	--2.45M
Minority interest income
Net income attributable to the parent company	-3.76%-5.06M	80.70%-10.88M	101.34%292K	92.22%-2.33M	-4,411.36%-3.97M	-7.95%-4.87M	31.79%-56.39M	65.29%-21.87M	-354.96%-29.92M	96.79%-88K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-3.76%-5.06M	80.70%-10.88M	101.34%292K	92.22%-2.33M	-4,411.36%-3.97M	-7.95%-4.87M	31.79%-56.39M	65.29%-21.87M	-354.96%-29.92M	96.79%-88K
Basic earnings per share	-8.82%-0.37	80.16%-0.76	101.33%0.02	92.12%-0.16	-2,700.00%-0.28	-9.68%-0.34	32.09%-3.83	65.12%-1.5	-351.11%-2.03	94.74%-0.01
Diluted earnings per share	-8.82%-0.37	80.16%-0.76	101.33%0.02	92.12%-0.16	-2,700.00%-0.28	-9.68%-0.34	32.09%-3.83	65.12%-1.5	-351.11%-2.03	94.74%-0.01
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm